Tscan Therapeutics Inc (TCRX) EPS is poised to hit -0.29 next quarter: How Investors Can Make It Count the Most?
Witnessing the stock’s movement on the chart, on Thursday, Tscan Therapeutics Inc (NASDAQ: TCRX) remained unchanged to $1.45, before settling in for the price of